Reynaldo Quintana

Reynaldo Quintana has served as Kedalion’s Senior Vice President of Research and Development since August 2018. Prior to Kedalion, he was Senior Director of Global Engineering at Fontem Ventures, B.V., leading product development for next-generation platforms. He also led mechanical device development at Alexza Pharmaceuticals which obtained US and EU approval for Adasuve®, the first inhalable treatment for acute agitation. Reynaldo has also held management positions with leading companies such as NJOY, Inc., ZOLL Medical Corporation (formerly Revivant), Aerogen, and IDEO, and has served as an engineering and product development consultant to Sunovion Pharmaceuticals, Genentech, and Elevation Pharmaceuticals. He is an inventor or co-inventor on 18 patents related to medical devices and drug delivery systems. Reynaldo received a B.S. in mechanical engineering from the University of Maryland College Park and a B.S. in physics from Frostburg State University, and an M.S. in biomedical engineering from The Catholic University of America.